Urinary Metal Levels Linked to Increased Risk for CVD, Mortality
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Aug. 7, 2024 -- Urinary metal levels are associated with an increased risk for cardiovascular disease (CVD) and all-cause mortality, according to a study published online Aug. 1 in Circulation.
Irene Martinez-Morata, M.D., Ph.D., from the Columbia University Mailman School of Public Health in New York City, and colleagues examined the prospective association of urinary metals with incident CVD and all-cause mortality in the racially diverse Multi-Ethnic Study of Atherosclerosis. Data were included for 6,599 participants with urinary metals available at baseline (2000 to 2001) who were followed through December 2019.
The researchers found that 1,162 participants developed CVD and 1,844 participants died during follow-up. Comparing the highest with the lowest quartiles, the hazard ratios for incident CVD and all-cause mortality were 1.25 and 1.68 for cadmium; 1.20 and 1.16 for tungsten; 1.32 and 1.32 for uranium; 1.24 and 1.37 for cobalt; 1.42 and 1.50 for copper; and 1.21 and 1.38 for zinc, respectively, in models adjusted by behavioral and clinical indicators. For cadmium and copper, a positive linear dose-response was seen with both end points. The adjusted hazard ratios for an interquartile range increase in the mixture of these urinary metals and 10-year survival probability difference for incident CVD and all-cause mortality were 1.29 and −1.1 percent and 1.66 and −2.0 percent, respectively.
"These findings support the role of metals as emerging and preventable risk factors for CVD and all-cause mortality and can inform the development of novel preventive strategies to improve cardiovascular health by mitigating the adverse effects of metals," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Adverse Pregnancy Outcomes Partly Mediate Association Between Prepregnancy Obesity, CVD Risk
MONDAY, April 21, 2025 -- Adverse pregnancy outcomes (APOs) mediate a small proportion of the association between prepregnancy obesity and cardiovascular disease (CVD) risk in...
Handheld Electro-Shockers Pose Risk for Interaction With Implantable Cardiac Devices
WEDNESDAY, April 9, 2025 -- When applied to cardiac implantable electronic devices (CIEDs), commercially available handheld electro-shockers pose a relevant risk for interaction...
Rural-Urban Differences Seen in Cardiometabolic Risk Factors, CVD
TUESDAY, April 8, 2025 -- There are substantial rural-urban disparities in cardiometabolic risk factors and cardiovascular diseases among U.S. adults, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.